VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AXSM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AXSMAxsome Therapeutics, Inc.
$132.37$6.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAXSMQuarterly Financials

Axsome Therapeutics, Inc. (AXSM) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Axsome Therapeutics, Inc. (AXSM) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

AXSM Income Statement

Quarterly statement

AXSM Income Statement

Axsome Therapeutics, Inc. (AXSM) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue259.69M218.38M191.2M196M170.99M150.04M121.46M118.77M104.76M87.17M75M71.53M57.79M46.7M94.58M24.37M16.85M8.82M00
Revenue Growth %51.87%45.54%57.42%65.03%63.22%72.13%61.95%66.04%81.27%86.65%-20.7%193.5%243.07%429.48%------
Cost of Goods Sold17.8M13.56M14.72M12.33M11.91M13.45M9.79M10.51M8.44M8.05M6.3M7.38M6.53M4.6M7.56M2.29M1.92M983K00
COGS % of Revenue6.86%6.21%7.7%6.29%6.97%8.96%8.06%8.85%8.05%9.24%8.4%10.31%11.3%9.85%7.99%9.4%11.42%11.15%--
Gross Profit241.89M204.81M176.48M183.67M159.08M136.59M111.67M108.25M96.33M79.11M68.7M64.15M51.26M42.1M87.02M22.08M14.92M7.84M00
Gross Margin %93.14%93.79%92.3%93.71%93.03%91.04%91.94%91.15%91.95%90.76%91.6%89.69%88.7%90.15%92.01%90.6%88.58%88.85%--
Gross Profit Growth %52.05%49.94%58.03%69.67%65.15%72.66%62.55%68.74%87.91%87.91%-21.05%190.54%243.53%437.21%------
Operating Expenses252.96M254.46M239.84M213.1M205.19M173.31M168.66M180.87M158.95M157.16M135.98M162.43M113.38M107.16M93.39M82M57.33M47.02M38.29M32.61M
OpEx % of Revenue97.41%116.52%125.43%108.73%120%115.51%138.85%152.29%151.72%180.3%181.31%227.07%196.18%229.46%98.75%336.45%340.34%533.08%--
Selling, General & Admin203.11M208.14M185M169.3M150.24M130.28M120.79M113.27M95.56M103.55M98.97M86.81M83.19M78.94M74.19M61.5M40.89M31.16M25.7M18.83M
SG&A % of Revenue78.21%95.31%96.75%86.38%87.86%86.83%99.44%95.37%91.22%118.8%131.96%121.36%143.94%169.03%78.45%252.33%242.74%353.29%--
Research & Development50.62M46.23M52.68M48.79M40.16M49.54M44.78M55.01M45.39M49.85M36.83M30.8M28.77M20.58M17.79M14.69M14.88M15.79M12.59M13.78M
R&D % of Revenue19.49%21.17%27.55%24.89%23.49%33.02%36.87%46.31%43.32%57.19%49.11%43.06%49.78%44.07%18.81%60.29%88.31%179.05%--
Other Operating Expenses-773K93K1000K-1000K1000K-1000K1000K1000K1000K1000K177K1000K1000K1000K1000K1000K1000K66K00
Operating Income-11.07M-49.65M-63.36M-29.43M-46.11M-36.71M-56.98M-72.62M-62.62M-78.05M-67.28M-98.27M-62.12M-65.06M-6.37M-59.92M-42.41M-39.18M-38.29M-32.61M
Operating Margin %-4.26%-22.73%-33.14%-15.02%-26.97%-24.47%-46.91%-61.14%-59.78%-89.54%-89.7%-137.39%-107.49%-139.31%-6.74%-245.85%-251.76%-444.23%--
Operating Income Growth %76%-35.22%-11.19%59.47%26.37%52.96%15.3%26.11%-0.81%-19.97%-955.46%-64.02%-46.47%-66.04%83.35%-83.75%-26.95%-27.01%-37.51%-17.53%
EBITDA-11.07M-46.76M-60.99M-27.16M-43.7M-34.47M-54.85M-70.54M-60.56M-76.05M-65.44M-96.53M-60.38M-62.91M-4.71M-57.9M-40.73M-38.79M-37.98M-32.3M
EBITDA Margin %-4.26%-21.41%-31.9%-13.86%-25.56%-22.97%-45.16%-59.4%-57.81%-87.25%-87.26%-134.96%-104.47%-134.71%-4.98%-237.57%-241.79%-439.77%--
EBITDA Growth %74.67%-35.66%-11.2%61.5%27.85%54.68%16.19%26.92%-0.31%-20.89%-1288.88%-66.72%-48.23%-62.19%87.59%-79.25%-23.03%-26.88%-37.73%-16.68%
D&A (Non-Cash Add-back)02.89M2.37M2.27M2.41M2.25M2.13M2.07M2.06M1.99M1.83M1.74M1.74M2.15M1.66M2.02M1.68M393.35K312K307.41K
EBIT-11.07M-49.65M-63.36M-26.96M-46.11M-44.82M-56.98M-72.62M-62.62M-78.05M-67.28M-98.27M-62.12M-65.06M-6.37M-59.92M-42.41M-39.18M-38.29M-32.61M
Net Interest Income-1.72M-1.54M-1.19M865K-1.12M-1.83M-2.43M-2.21M-1.98M-1.3M-1.08M-702K-757K-2.73M-2.26M-1.32M-2.41M-2.26M-1.34M-1.37M
Interest Income0002.04M0000000000000000
Interest Expense1.72M1.54M1.19M1.17M1.12M1.83M2.43M2.21M1.98M1.3M1.08M702K757K2.73M2.26M1.32M2.41M2.26M1.34M1.37M
Other Income/Expense-1.72M-1.54M-1.19M1.3M-1.12M-12.22M-2.43M-2.21M-1.98M-1.3M-1.08M-702K-757K-2.73M-2.26M-1.32M-2.41M-2.26M-1.34M-1.37M
Pretax Income-12.79M-51.19M-64.54M-28.13M-47.23M-48.93M-59.41M-74.83M-64.6M-79.34M-68.36M-98.98M-62.88M-67.79M-8.64M-61.24M-44.82M-41.44M-39.63M-33.98M
Pretax Margin %-4.92%-23.44%-33.76%-14.35%-27.62%-32.61%-48.91%-63%-61.67%-91.03%-91.14%-138.37%-108.8%-145.15%-9.13%-251.28%-266.08%-469.82%--
Income Tax88K128K0430K0-960K085K000-325K-678K-617K2.58M00000
Effective Tax Rate %-0.69%-0.25%0%-1.53%0%1.96%0%-0.11%0%0%0%0.33%1.08%0.91%-29.87%0%0%0%0%0%
Net Income-12.88M-51.31M-64.54M-28.56M-47.23M-47.97M-59.41M-74.91M-64.6M-79.34M-68.36M-98.65M-62.2M-67.17M-11.22M-61.24M-44.82M-41.44M-39.63M-33.98M
Net Margin %-4.96%-23.5%-33.76%-14.57%-27.62%-31.97%-48.91%-63.08%-61.67%-91.03%-91.14%-137.92%-107.62%-143.83%-11.86%-251.28%-266.08%-469.82%--
Net Income Growth %72.73%-6.96%-8.63%61.88%26.89%39.54%13.08%24.06%-3.86%-18.13%-509.35%-61.09%-38.77%-62.1%71.69%-80.24%-28.5%-28.35%-35.45%-16.5%
Net Income (Continuing)-12.88M-51.31M-64.54M-28.56M-47.23M-47.97M-59.41M-74.91M-64.6M-79.34M-68.36M-98.65M-62.2M-67.17M-11.22M-61.24M-44.82M-41.44M-39.63M-33.98M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.25-0.99-1.26-0.56-0.94-0.97-1.22-1.54-1.34-1.67-1.44-2.08-1.32-1.54-0.26-1.41-1.07-1.06-1.03-0.90
EPS Growth %73.4%-2.06%-3.28%63.64%29.85%41.92%15.28%25.96%-1.52%-8.44%-453.85%-47.52%-23.36%-45.28%74.76%-56.67%-15.05%-23.26%-32.05%-15.38%
EPS (Basic)-0.25-0.99-1.26-0.56-0.94-0.97-1.22-1.54-1.34-1.67-1.44-2.08-1.32-1.54-0.26-1.41-1.07-1.06-1.03-0.90
Diluted Shares Outstanding52.45M51.5M51.2M50.63M50.02M49.44M48.87M48.54M48.14M47.57M47.39M47.33M47.12M43.67M43.52M43.45M41.7M39.08M38.32M37.76M
Basic Shares Outstanding52.45M51.5M51.2M50.63M50.02M49.44M48.87M48.54M48.14M47.57M47.39M47.33M47.12M43.67M43.52M43.45M41.7M39.08M38.32M37.76M
Dividend Payout Ratio--------------------